References
- Alivisatos S G. A, Ungar F, Abraham G. Non-enzymatic interactions of reduced coenzyme I with inorganic phosphate and certain other anions. Nature (Lond.) 1964; 203: 973
- Amador E, Urban J. Transphosphorylation by human alkaline phosphatase. Amer. J. clin. Path 1972; 57: 167
- Applegarth P A, Eden J. Deterioration of solutions of reduced nicotinamide adenine dinucleotide (NADH2) during storage. Clin. chim. Acta 1966; 13: 720
- Bergmeyer H U, Berut E, Grassl M, Michal G. Methoden der enzymatischen Analyse, H. U Bergmeyer. Verlag Chemie. 1970; vol. 1.: 125, 442, 446, 485, 534
- Ebeling J, Meijers C A. M, Spijkers J B. F. The use of TRIS buffer for U.V. spectrophotometric assay of GOT and GPT. Clin. chim. Acta 1969; 25: 174
- Ellis G, Goldberg D M. Comparison of aminotransferase activities as determined by the original, revised and optimum spectrophotometric methods. Clin. chim. Acta 1971; 35: 241
- Empfehlungen der Deutschen Gesellschaft für Klinische Chemie Standardisierung von Methoden zur Bestimmung von Enzymaktivitäten in biologischen Flüssigkeiten. Z. klin. Chem. 1972; 10: 281
- Fawcett C P, Ciotti M M, Kaplan N O. Inhibition of dehydrogenase reactions by a substance formed from reduced diphosphopyridine nucleotide. Biochim. biophys. Acta (Amst.) 1961; 54: 210
- Gay R J, McComb R B, Bowers G N. Optimum reaction condition for human lactate isoenzymes as they affect total LDH activity. Clin. Chem 1968; 14: 740
- Gerhardt W, Kofoed B, Westlund L, Pavlu B. Quality Control of NADH. Evaluation of Methods for Detection of Inhibitors and Specifications for NADH Quality. Scand. J. clin. Lab. Invest 1974; 33, Suppl. 139
- Härtel A, Helger R, Lang H. Einfluss der Reagentien auf die Messwerte bei LDH- und Transaminasen-Bestimmungen. Z. klin. Chem 1968; 6: 259
- Hamfelt A. The effect of pyridoxal phosphate on the aminotransferase assay in blood. Scand. J. clin. Lab. Invest 1966; 18: 181, Suppl. 92
- Hausamen T U, Helger R, Rick W, Gross W. Optimal condition for the determination of serum alkaline phosphatase by a new kinetic method. Clin. Chim. Acta 1968; 15: 241
- Henry J H. Revised spectrophotometric method for the determination of glutamicoxalacetic, glutamic-pyruvic and lactic acid dehydrogenase. Amer. J. clin. Path 1960; 34: 381
- James J, Johnson A, Schaffer R. Work at N.B.S. Developing NADH as a Standard Reference Material. International seminar and workshop on Enzymology. Chicago 1972
- Karmen A. A note on the spectrophotometric assay of glutamic-oxalacetic transaminase in human blood serum. J. clin. Invest 1955; 34: 131
- Laudahn G, Hartmann E, Rosenfeld E M, Weyer H, Muth H W. Normal-werte der Serum-Transaminasen bei Verwendung substrat-optimierter Testansätze zur Aktivitätsbestimmung. Klin. Wschr 1970; 48: 838
- Lowry O H, Passonneau J V, Rock M K. The stability of pyridine nucleotides. J. biol. Chem 1961; 236: 2756
- McComb R B, Gay J R. A comparison of reduced NAD preparations from four commercial sources. Clin. Chem 1968; 14: 754
- Specifications and criteria for biochemical compounds. National Academy of Sciences. National Research Council., Washington 1967, publ. 1344.
- Strandjord P E, Clayson K J. The control of inhibitory impurities in reduced nicotinamide adenine dinucleotide in lactate dehydrogenase assays. J. Lab. clin. Med 1966; 67: 144
- Winer A D, Schwert G W. Lactate Dehydrogenase IV: The influence of pH on the kinetics of the reaction. J. biol. Chem 1958; 231: 1065
- Wrobleski F, LaDue J S. Lactic dehydrogenase activity in blood. Proc. Soc. exp. Biol. (N.Y.) 1955; 90: 210